CORRECTION article
Front. Pharmacol.
Sec. Experimental Pharmacology and Drug Discovery
Correction: Editorial: Opportunities and challenges in drug repurposing
Provisionally accepted
- Institute of Exact Sciences, Federal University of Alfenas, Alfenas, Brazil
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Correction on: Camps I, Künzel SR, Schubert M and Singh RK (2025) Editorial: Opportunities and challenges in drug repurposing. Front. Pharmacol. 16:1709217. doi: 10.3389/fphar.2025.1709217 The accession date was omitted for reference "Maida, 2024". It should be "Maida, J. ( 2024). Drug repurposing market to grow by USD 8.57 billion (2024USD 8.57 billion ( -2028) ) as cancer treatment applications expand, AI-driven market transformation report -technavio. Cleveland, OH, United States: PR Newswire Website. Available online at: https://www.prnewswire.com/news-releases/drug-repurposing-markettogrow-by -usd-8-57-billion-2024-2028-as-cancer-treatment-applications-expand-aidriven-markettransformation-report-technavio-302292477.html. (Accessed September 17, 2025)".The accession date was omitted for reference "Sperry and Ingber, 2024". It should be "Sperry, M., and Ingber, D. (2024). Drug repurposing strategies, challenges and successes. Website Technol. Drug Discov.
Keywords: drug repurposing, Drug Repositioning, Challenges, opportunities, artificial intelligence, bioinformatics
Received: 29 Oct 2025; Accepted: 30 Oct 2025.
Copyright: © 2025 Camps. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Ihosvany Camps, icamps@unifal-mg.edu.br
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.